Alnylam and Tenaya sign $1.23bn cardiovascular target discovery deal [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
Alnylam Pharmaceuticals has forged a discovery collaboration worth up to $1.23bn with cardiovascular disease specialist, Tenaya Therapeutics. Through this partnership, Alnylam will harness Tenaya's capabilities to identify up to 15 novel genetic targets involved in heart disease. In return, Alnylam will hand over up to $10m upfront, while pledging to pay out up to $1.13bn in development and commercial milestone payments linked to any drugs created through the partnership. However, Tenaya bears responsibility to yield targets up to Alnylam's standards, as the $10m upfront fee could be subject to a $500k reduction per candidate for up to eight nominated targets that don't meet the latter company's criteria. Once these targets have been identified, Alnylam and Tenaya will collaborate for around two years to mutually validate them through both in vitro and in vivo methods. Under the terms of this deal, Alnylam will reimburse Tenaya for “full-time employees and out-of-pocket costs a
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Tenaya Therapeutics inks $1.13 billion deal with Alnylam for heart-disease treatments [Yahoo! Finance]Yahoo! Finance
- Helix Announces Multi-Year Agreement with Alnylam to Drive Precision Medicine Development [Yahoo! Finance]Yahoo! Finance
- Alnylam's research pact worth up to $1.1B sends Tenaya higher [Seeking Alpha]Seeking Alpha
- Alnylam Reimbursement Win And Trial Progress Versus Current Valuation Signals [Yahoo! Finance]Yahoo! Finance
- Alnylam Pharmaceuticals Touts AMVUTTRA Momentum, Teases Key Pipeline Readouts at TD Cowen Conf. [Yahoo! Finance]Yahoo! Finance
ALNY
Earnings
- 2/12/26 - Beat
ALNY
Sec Filings
- 3/5/26 - Form 144
- 3/5/26 - Form 144
- 3/4/26 - Form 4
- ALNY's page on the SEC website